Physician profile
James C Prueter
NPI 1649525684
$8,549.11
in general payments reported to CMS, 2019-2025
17 companies · $5,719 in 2025
The $5,719 reported for 2025 was more than what 96% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $517 · 2020: $69.93 · 2021: $159 · 2022: $497 · 2023: $746 · 2024: $841 · 2025: $5,719.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $3,200 · Food and Beverage: $2,627 · Travel and Lodging: $1,478.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $3,200.00 |
| Food and Beverage | $2,627.24 |
| Travel and Lodging | $1,478.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cochlear Americas | $5,932.98 | 2019-2025 | Osia Osi300 Implant, Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode, Baha |
| Stryker Corporation | $619.07 | 2019-2025 | Audion Et Dilation System, Scopis Ent, Latera |
| Genzyme Corporation | $301.60 | 2019-2025 | |
| Medtronic, INC. | $285.18 | 2021-2025 | Propel, Ligasure |
| Med-El Corporation | $255.70 | 2024 | Mi1250 Synchrony 2 Flexsoft, Adhear Professional Kit, Bci 602 Kit |
| Acclarent, INC | $223.43 | 2020-2024 | Acclarent Aera, Trudi Nav Cable, Acclarent Balloon Inflation Device |
| Abbvie INC. | $188.17 | 2022-2024 | |
| Regeneron Healthcare Solutions, INC. | $161.12 | 2023-2025 | Dupixent |
| Phathom Pharmaceuticals, INC. | $125.00 | 2024 | Voquezna |
| Medtronic USA, INC. | $110.53 | 2019 | |
| Optinose US, INC. | $102.19 | 2019-2023 | |
| Alk-Abello, INC | $72.60 | 2020-2022 | |
| Integra Lifesciences Corporation | $56.95 | 2019 | |
| Smith+Nephew, INC. | $42.37 | 2019 | |
| Genentech USA, INC. | $41.19 | 2022-2023 | Xolair |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aerin Medical INC. | $16.65 | 2021 | |
| Kaleo, INC. | $14.38 | 2023 | Auvi-Q |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Prueter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.